Synthetic biology startup Huue, founded by BioE PhD alumni Tammy Hsu, has raised $14.6 million in a Series A funding round for what it says is the world’s first clean and scalable indigo dye for denim.
BioE News
David Schaffer: Research that takes risks must be supported
Professor David Schaffer reflects on the reasons why he sees Berkeley as a leader in world-changing research, innovation and entrepreneurship.
Human lung proteins can advance or thwart SARS-CoV-2 infections
A study led by Prof Patrick Hsu has identified specific proteins within our bodies that can promote or protect us from SARS-CoV-2 infections, potentially opening the door to new antiviral therapies. Notably, they showed that mucins — the main component of mucus found in the lungs — seem to help block the SARS-CoV-2 virus from entering cells.
Bacteria for Blastoff: Using Microbes to Make Supercharged New Rocket Fuel
New research led by Professor Jay Keasling took inspiration from an extraordinary antifungal molecule made by Streptomyces bacteria to develop a totally new type of fuel that has projected energy density greater than the most advanced heavy-duty fuels used today, including the rocket fuels used by NASA.
Streets and Yartsev promoted to Associate Professor
Congratulations to new Associate Professors Aaron Streets and Michael Yartsev, granted tenure effective July 1, 2022!
Head-Gordon Pursuing AI-driven Drug Discovery at New NIH Center
Professor Teresa Head-Gordon will continue the machine learning COVID-19 research spurred by a 2020 Digital Transformation Institute grant, with the Midwest Antiviral Drug Discovery Center for Pathogens of Pandemic Concern, one of nine new centers announced by the National Institute of Allergy and Infectious Diseases on May 18, 2022.
Schaffer named Executive Director of QB3
David Schaffer, PhD, a University of California, Berkeley professor of chemical and biomolecular engineering, bioengineering, and molecular and cell biology, who holds over 50 patents and whose research has spawned eight companies to commercialize stem cell and gene therapies, has been appointed the next executive director of QB3.
Decoding the Human Proteome With Glyphic Biotechnologies
Check out this feature on Bakar Labs startup Glyphic Biotechnologies – co-founded by MTM alumnus Josh Yang!
Messersmith receives Bakar Fellows Spark Award
Congratulations to Professor Phillip Messersmith, one of seven new recipients of the 2022 Bakar Fellows Spark Award, designed to accelerate faculty-led research and produce tangible, positive societal impact through commercialization. Messersmith is developing a regenerative therapy for the intestinal ulcers that accompany inflammatory bowel disease.